[an error occurred while processing this directive] | ����Ƥ���Բ�ѧ��־ 2003, 29(6) 358-360 DOI: ISSN: 2096-5540 CN: 32-1880/R | ||||||||||||||||||||||||||||||||||||||||||||||
����Ŀ¼ | ����Ŀ¼ | ������� | ������ [��ӡ��ҳ] [�ر�] | |||||||||||||||||||||||||||||||||||||||||||||||
���� |
| ||||||||||||||||||||||||||||||||||||||||||||||
���ʽ�������ø������֯�� | |||||||||||||||||||||||||||||||||||||||||||||||
���ĺ�, ֣�� | |||||||||||||||||||||||||||||||||||||||||||||||
�㽭��ѧҽѧԺ�����ڶ�ҽԺƤ����, ���� 310009 | |||||||||||||||||||||||||||||||||||||||||||||||
ժҪ��
���ʽ�������ø��һ���������������ϸ������ʽ���ø,�����ڿ��ɶ��ֻ���ϸ������֢ϸ������,�����巢������֯�ؽ���������֢��Ӧ��������Ϯ��ת�Ƶȹ����з�����Ҫ����.���Ի��ʽ�������ø�����������Խ����֯���Ĺ�ϵ��һ����. | |||||||||||||||||||||||||||||||||||||||||||||||
�ؼ����� ���ʽ�������ø ��������ø����֯���Ƽ� �����֯���� | |||||||||||||||||||||||||||||||||||||||||||||||
Abstract: | |||||||||||||||||||||||||||||||||||||||||||||||
Keywords: | |||||||||||||||||||||||||||||||||||||||||||||||
�ո����� 2003-01-10 ������ ����淢������ | |||||||||||||||||||||||||||||||||||||||||||||||
DOI: | |||||||||||||||||||||||||||||||||||||||||||||||
������Ŀ: | |||||||||||||||||||||||||||||||||||||||||||||||
ͨѶ����: | |||||||||||||||||||||||||||||||||||||||||||||||
�����: | |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
�ο����ף� | |||||||||||||||||||||||||||||||||||||||||||||||
[1] Sternlicht MD,Werb Z.How matrix metalloproteinases regulate cell behavior.Annu Rev Cell Dev Biol,2001,17:463-516. [2] Corbel M,Belleguic C,Boichot E,et al.Involvement of gelatinases(MMP-2 and MMP-9)in the development of airway inflammationand pulmonary fibrosis.Cell Biol Toxicol,2002,18(1):51-61. [3] Leeman MF,Curran S,Murray GI.The structure,regulation,and function of human matrix metalloproteinase-13.Crit Rev BiochemMol Biol,2002,37(3):149-166. [4] Khasigov PZ,Podobed OV,Ktzoeva SA,et al.Matrix metalloproteiases of normal human tissues.Biochemistry(Mosc),2001,66(2):130-140. [5] Rydziel S,Durant D,Canalis E.Platelet-derived growth factor induces collagenase 3 transcription in osteoblasts through the activator protein 1 complex.J Cell Physiol,2000,184(3):326-333. [6] Lijnen HR.Matrix metalloproteinases and cellular fibrinolytic activity.Biochemistry(Mosc),2002,67(1):92-98. [7] Brew K,Dinakarpandian D,Nagase H.Tissue inhibitors of metalloproteinases:evolution,structure and function.Biochim Biophys Acta,2000,1477(1-2):267-283. [8] Lohi J,Wilson CL,Roby JD,et al.Epilysin,a novel human matrix metalloproteinase(MMP-28)expressed in testis and keratinocytes and in response to injury.J B iol C hem,2001,276(13):10134. [9] Kotajima L,Aotsuka S,Fujimani M,et al.Increased levels of matrix metalloproteinase-3 in sera from patients with active lupus nephritis.Clin Exp Rheumatol,1998,16(4):409-415. [10] Zucker S,Mian N,Drews M,et al.Increased serum stromelysin-1 levels in systemic lupus erythematosus:lack of correlation with disease activity.J Rheumatol,1999,26(1):78-80. [11] Zucker S,Hymowitz M,Conner C,et al.Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues.Clinical and experimental applications.Ann N Y Acad Sci,1999,878:212-227. [12] Ribbens C,Martin y Porras M,Franchimont N,et al.Increased matrix metalloproteinase-3 serum levels in rheumatic diseases:relationship with synovitis and steroid treatment.Ann Rheum Dis,2002,61(2):161-166. [13] Faber-Elmann A,Sthoeger Z,Tcherniack A,et al.Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus.Clin Exp Immunol,2002,127(2):393-398. [14] Kieseier BC,Schneider C,Clements JM,et al.Expression of specific matrix metalloproteinases in inflammatory myopathies.Brain,2001,124(Pt 2):341-351. [15] Choi YC,Dalakas MC.Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.Neurology,2000,54(1):65-71. [16] Young-Min SA,Beeton C,Laughton R,et al.Serum TIMP-1,TIMP-2,and MMP-1 in patients with systemic sclerosis,primary Raynaud's phenomenon,and in normal controls.Ann Rheum Dis,2001,60(9):846-851. [17] Yazawa N,Kikuchi K,Ihn H,et al.Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosis.J Am Acad Dermatol,2000,42(1Pt 1):70-75. [18] Kikuchi K,Kubo M,Hoashi T,et al.Decreased MMP-9 activity in the serum of patients with diffuse cutaneous systemic sclerosis.Clin Exp Dermatol,2002,27(4):301-305. [19] Perez P,Goicovich E,Alliende C,et al.Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjogren's syndrome.Arthritis Rheum,2000,43(12):2807. [20] Tolboom TC,Pieterman E,van der Laan WH,et al.Invasive properties of fibroblast-like synoviocytes:correlation with growth characteristics and expression of MMP-1,MMP-3,and MMP-10.Ann Rheum Dis,2002,61(11):975-980. [21] Petrow PK,Wernicke D,Schulze Westhoff C,et al.Characterisation of the cell type-specificity of collagenase 3 mRNA expression in comparison with membrane type 1 matrix metalloproteinase and gelatinase A in the synovial membrane in rheumatoid arthritis.Ann Rheum Dis,2002,61(5):391-397. [22] Cunnane G,Fitzgerald O,Beeton C,et al.Early joint erosions and serum levels of matrix metalloproteinase 1,matrix metalloproteinase 3,and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis.Arthritis Rheum,2001,44(10):2263-2274. [23] Close DR.Matrix metalloproteinase inhibitors in rheumatic diseases.Ann Rheum Dis,2001,60(Suppl 3):iii62-67. |
|||||||||||||||||||||||||||||||||||||||||||||||
������������� | |||||||||||||||||||||||||||||||||||||||||||||||
1������ǿ,�̲�.�����ش�ë�����������о���չ[J]. ����Ƥ���Բ�ѧ��־, 2007,33(4): 244- | |||||||||||||||||||||||||||||||||||||||||||||||
2����ȼ �±�.�����Ե�����֯���Լ������[J]. ����Ƥ���Բ�ѧ��־, 2011,37(6): 380-383 | |||||||||||||||||||||||||||||||||||||||||||||||
3�������� ������.���ʽ�������ø����ʽ�������ø���Ƽ��ڹ��ϻ������õ��о���չ[J]. ����Ƥ���Բ�ѧ��־, 2012,38(3): 163-166 | |||||||||||||||||||||||||||||||||||||||||||||||
4������ �浤.���ʽ�������ø��Ƥ���������[J]. ����Ƥ���Բ�ѧ��־, 2007,33(1): 53-53 | |||||||||||||||||||||||||||||||||||||||||||||||
5���Ժ�� ���.���ʽ�������ø������Ƥ������[J]. ����Ƥ���Բ�ѧ��־, 2007,33(3): 148-148 | |||||||||||||||||||||||||||||||||||||||||||||||
6���º������, ��������У.Ƥ���еĻ��ʽ�������ø[J]. ����Ƥ���Բ�ѧ��־, 1999,25(2): 104-106 | |||||||||||||||||||||||||||||||||||||||||||||||
7���ļ�ƽ, ��־��.Ƥ�����ϻ������о���չ[J]. ����Ƥ���Բ�ѧ��־, 2002,28(5): 288-291 | |||||||||||||||||||||||||||||||||||||||||||||||
8������, ������.Ƥ����״ϸ�����ͻ���ϸ�������ʽ�������ø��P��������ת�ƵĹ�ϵ[J]. ����Ƥ���Բ�ѧ��־, 2004,30(3): 176-178 | |||||||||||||||||||||||||||||||||||||||||||||||
9������, �浤.���ʽ�������ø��Ƥ���������[J]. ����Ƥ���Բ�ѧ��־, 2007,33(1): 53-55 | |||||||||||||||||||||||||||||||||||||||||||||||
10���Ժ��, ���.���ʽ�������ø������Ƥ������[J]. ����Ƥ���Բ�ѧ��־, 2007,33(3): 148-150 | |||||||||||||||||||||||||||||||||||||||||||||||
11���º�, �ィ��.���ʽ�������ø�����Ƥ��������[J]. ����Ƥ���Բ�ѧ��־, 2007,33(3): 151-153 | |||||||||||||||||||||||||||||||||||||||||||||||
�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���ص�����!�������ݲ�����վ�۵�.) | |||||||||||||||||||||||||||||||||||||||||||||||
Copyright 2008 by ����Ƥ���Բ�ѧ��־ |